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ABSTRACT 
 
 
The Effect of Cadmium on Chicken Embryo Heart Development  
 
 
Mahi Basra and Nicole DePadova 
Departments of Public Health and Biomedical Sciences 
Texas A&M University 
 
 
Research Advisor: Dr. Linglin Xie 
Department of Nutrition and Food Science 
Texas A&M University 
 
 
This study aims to elucidate the effect of cadmium (Cd) on chicken embryo heart 
development. Cd is a hazardous chemical found commonly in cigarette smoke and in food 
sources due to environmental contaminants. Cd is known to bioaccumulate in organ tissues to 
cause carcinogenic effects. Our study investigates the effect of Cd exposure during early 
gestation on embryonic heart development. Phenotypic results show an increasingly hyperplastic 
myocardial wall associated with increasing CdCl2 dosage and earlier exposure. This semester, we 
will be using staining through apoptotic markers to determine the mechanism of transport of zinc 
and cadmium through the embryo. Biochemical analyses and assays will be conducted to further 
inquire the biological and molecular processes that result in the observed phenotypic changes 
associated with CdCl2 exposure. We hope to elucidate the mechanism of Cd cardiotoxicity in 
embryonic development to contribute to identifying susceptibility and treatments for Cd 
exposure in utero.   
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NOMENCLATURE 
 
 
Cd  Cadmium 
 
Zn  Zinc 
 
HH  Hamburger-Hamilton 
 
HE  Hematoxylin and eosin 
 
qPCR  Quantitative polymerase chain reaction 
 
ICP-MS Inductively coupled plasma mass spectrometry 
 
PBS  Phosphate buffered saline 
 
DEPC  Diethyl pyrocarbonate 
 
IHC  Immunohistochemistry 
 
LD50  Lethal dose 50 
 
DORV  Double outlet right ventricle 
 
PTA  Persistent truncus arteriosus 
 
OA  Overriding aorta 
 
VSD  Ventricular septal defect 
 
ED50  Effective dose 50 
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CHAPTER I 
INTRODUCTION 
 
 
As determined by the Center for Disease Control (CDC), Cadmium (Cd) is the 7th 
highest priority substance heavy metal. 1 Cd is commonly found in phosphate fertilizers, nickel-
Cd batteries, plastic stabilizers, pigments, cigarette smoke, some chemical wastes and 
contaminated foods.2, 3, 4 
Cd Exposure Routes 
Humans can be exposed to Cd in a variety of ways including through inhalation (5-50%), 
ingestion of contaminated food (1-10%) and a very insignificant amount through skin contact.5 
Exposure via inhalation can occur through inhalation of cigarette smoke; approximately 0.1-0.2 
mg of Cd is inhaled per cigarette smoked.3,6 After absorption, Cd bioaccumulates throughout the 
body.5 Within kidney tissue, the half-life of Cd is between 6-38 years and is between 4-19 years 
within human liver tissue.5 For all other human tissues, the half-life of Cd ranges from 9-47 
years.5 Another common route of exposure for humans is through ingestion of contaminated 
dietary products such as mushrooms, seafood, vegetables (up to 150 μg Cd/kg), fruits (up to 50 
μg Cd/kg) and previously contaminated animal kidneys.4 
Effect of Cd Toxicity in Humans 
Cadmium is recognized as a carcinogen in humans, and exposure to Cd increases the risk 
of being diagnosed with breast and renal cancer.7,8,9 Furthermore, chronic Cd poisoning was 
shown to increase the risk for liver damage, pneumonia, gastrointestinal, cardiovascular and 
renal diseases.9 During pregnancy, Cd exposure has been associated with restricted growth in the 
fetus.10 
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Effect of Cd Toxicity in Animals 
Studies on animal Cd exposure have shown Cd accumulation in fetal tissue when the 
mother is exposed during pregnancy ultimately causing fetal growth restriction.11 The bulk of Cd 
research that has been conducted has focused on exposure in young and adult vertebrates. 
Studies have shown Cd exposure causes cardiovascular inflammation in rats, thinner ventricular 
walls in chickens and an overall reduced heart weight in chicken embryos.12, 13 Morphological 
abnormalities were also observed in animals exposed to Cd in later developmental stages of their 
lives.14 Other studies concerning Cd exposure in chickens have shown that abnormalities in the 
cephalic, liver and reproductive systems occurred as a result.14, 15, 16 However, many of the 
effects and mechanisms on the early stages of development are unexplored. Figure 1 summarizes 
the routes of entry of Cd in human and animal tissue along with the most common effects it has. 
 
 
Figure 1. Common routes of entry in Cd toxicity  
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Objective and Hypothesis 
 The objective of our research is to elucidate the teratogenic effects of cadmium exposure 
during early stages of chicken embryonic myocardium development. Our hypothesis is that, due 
to the extensive myocardium development that takes place between HH 13-16 and HH 27-28, we 
expect to see an increase in heart abnormalities with increasing Cd dosage compared to the 
chicken saline control.  
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CHAPTER II 
MATERIALS AND METHODS 
 
 
Experimental Design 
 To assess the effect of cadmium injection on embryonic heart development, varying 
concentrations of cadmium chloride, either 10 µM, 50 µM, 100 µM or a saline control, were 
injected into Gallus gallus single-comb White Leghorn eggs. The eggs were divided into two 
groups and injected with cadmium chloride (CdCl2) solution at either Hamburger-Hamilton (HH) 
Stage 13-16 (2 days after fertilization) or HH Stage 27-28 (5 days after fertilization), times when 
significant myocardial development takes place. They were incubated in a rocking egg incubator 
at 39 °C ± 0.5 °C until the time of collection. All of the eggs were collected at either five or nine 
days after fertilization depending on technique being performed. Cadmium concentrations in the 
yolk and amniotic fluid were measured at the time of sample collection. The eggs were then 
processed by utilizing histological techniques such as Paraffin embedding and HE staining in 
order to view each heart under a high-power microscope. A further overview of the experimental 
design is provided below in Figure 2.  
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Figure 2. Sample injection and collection timeline for histologic analysis 
Cd Solution Preparation and In-Ovo Injection of Solutions 
For the saline control, chicken saline solution was prepared using NaCl (8.47 g), CaCl2 
(0.79 g), MgCl2 (0.162 g), KCl (0.4 g). Each egg received 100 mL of either saline or cadmium 
chloride. The amount of cadmium chloride was calculated using Equation 1. The weight of each 
individual egg was measured to determine the CdCl2 concentration necessary, and the solution 
was diluted to 100 mL with saline. A sample calculation for a 100 µM injection is provided 
below in Table 1.  
Sample Calculation: V1= M2V2/ M1                   (Eq. 1) 
Table 1. Sample injection calculation for CdCl2 
Concentration 
Needed 
Volume Formula Solution 
100 µM 10 mL  V1=[1X10^-
4/1000mLX10mL]/[0.1/1000mL] 
Use 10 µL of 0.1 M in 10 
mL of saline 
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Eggs were divided between HH 13-16 and HH 27-28 injection groups with an even 
number in each treatment group. Injection protocol was based on a previous study by Ko, et al. 
2013.20 To inject the calculated solution through the inner membrane, forceps were used to make 
a hole approximately ± 0.5 cm2 at the top of each egg. The treatment amount was injected via 
100 µM pipet under vent hood UV light, and the hole was covered with gauze tape before being 
placed back into the rocking egg incubator. 
Sample Collection 
Embryos utilized for qPCR and ICP-MS were injected at day 2 and collected at day 5 or 
injected at day 5 and collected at day 9. Embryos for histology were injected at either day 2 or 
day 5 and collected at day 9. For collection, the gauze tape was removed and a larger hole in the 
top of the shell was created. Survival rate and fertilization status were recorded. Amniotic fluid 
and yolk were collected for histology studies and placed into separate 1.5 mL Eppendorf tubes. 
For qPCR and Cd and Zn concentration studies, the yolk, amniotic fluid, atrium, ventricles, and 
embryo were each individually collected. The embryo was placed into a petri dish with PBS to 
wash (or PBS + DEPC for qPCR embryos) and relocated to a well plate 70% full of 10% 
formalin. Pictures of the embryonic limbs were taken while in the PBS solution. After two days 
in the formalin solution, each embryo was removed and the lower portion of the body from the 
liver down was removed with microscissors. Additionally, the head and neck were removed. To 
embed the samples for tissue sectioning, they were incubated in paraffin and embedded in plastic 
cassettes using paraffin wax. In samples utilized for qPCR, the heart was dissected out and split 
into left and right atria before being stored in Trizol solution.  
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Histology Techniques 
Hematoxylin and Eosin Staining 
Samples for staining were cooled in an ice bath, sectioned using a Microtome at 5 µM 
thickness, and placed onto slides for staining. To begin HE staining, all slides were dried and 
incubated overnight at 60 °C. Xie Lab’s Hematoxylin & Eosin Staining protocol was followed to 
stain each slide as follows: incubation at 60 ℃ (minimum 40 mins), xylene two times (5 mins 
each), 100% EtOH two times (2 min each), 90% EtOH (2 mins), 70% EtOH (2 mins), wash in 
running tap water (2 mins), Hematoxylin (1.5 mins), wash in running tap water (5 mins), Eosin-
Y (1 min), wash in running tap water (2 mins), dry overnight, and apply a mounting coverslip 
glass. 
Qualitative Analysis Visual Identification Hyperplastic Myocardium 
All stained tissue samples were analyzed for a visual phenotype of hyperplastic 
myocardium, the experimental condition, using two criteria. Hyperplastic myocardium was 
determined to be present when (1) the sample had a greater amount of trabeculations when 
compared to the saline control or (2) had less open space in the ventricle than overall 
myocardium area. If the hyperplastic myocardium phenotype was present in a specific ventricle 
for a sample, it was indicated as a 1. The normal phenotype indicated as 0 for statistical analysis.  
Quantitative Analysis Myocardium Tissue Coverage 
 Three model samples where both valves were visible in a single slide were selected for 
each day in each group: saline control, 10 µM, 50 µM, 100 µM. Three students each measured 
the myocardium area of the left and right ventricles for day 2 and day 5 embryos using ImageJ 
software. Stipulations for where to measure each embryo were verbalized to all students. A ratio 
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of myocardium tissue percentage was calculated by measuring the entire ventricle area and 
dividing by the myocardium area (area % = area of myocardium / area of ventricle x 100%).  
Quantitative Image Analysis 
Image J Protocol 
The protocol was adapted from Mr. Jie Wu, a former student of Dr. Zhang, whose 
previous work used coding to take measurements in this software. The protocol was utilized to 
measure myocardium tissue coverage for all selected model samples for both day 2 and day 5 
embryos.  
ImageScope Protocol 
This protocol was utilized to measure the ventricular wall. Each student measured five 
individual embryo sections on a slide for each of 21 embryo samples using a single blinded 
technique whereby the treatment type was unknown. Eight measurements were taken total, four 
on the left ventricle and four on the right according to the following predetermined criteria: 
Measurement 1 is at the root of the ventricular valve. Measurements 2 and 3 were evenly spaced 
along the ventricle wall. Measurement four was taken at the thickest portion of the ventricle. 
Cd and Zn Concentration Measurement 
Inductively coupled plasma mass spectrometry (ICP-MS) was performed to analyze the 
respective concentrations of cadmium and zinc in the embryonic yolk. Eggs were divided into 
equal groups and injected either at day 2 and collected at day 5 or injected at day 5 and collected 
at day 9. The injection solution contained either saline control, 10 µM cadmium, 10 µM zinc, 50 
µM cadmium or 50 µM zinc. To digest the yolk for analysis, 0.1 grams of yolk was combined 
with the amount of metal present in either the blank or matrix spike and 400 µL nitric acid. The 
solution was incubated in a cryogenic vial at 90 °C for three hours and cooled for 20 minutes 
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before adding an additional 300 µL nitric acid and 300 µL hydrogen peroxide. This was heated 
for 1 hour at 85 °C. After cooling to room temperature, 1 mL 1% nitric acid was added and the 
mixture was moved into a 15 mL tube for machine analysis. The calibration standards for the 
machine were as follows: Zn: 1 ppb, 5 ppb, 10 ppb, 100 ppb, 200 ppb, Cd: 0.01 ppb, 0.05 ppb, 
0.1 ppb, 0.5 ppb, 1 ppb. Standards were created by taking a designated amount of solution for 
each respective sample and diluting to 50 mL with 1% nitric acid. Once a pressure of 250 psi and 
a temperature below 15 °C was reached, the samples were run through the machine and ion 
concentrations were analyzed. 
Quantitative Polymerase Chain Reaction  
Quantitative PCR was utilized to identify genotypic changes caused by cadmium 
injection. Embryos were collected at either day 5 or day 9 based on time of cadmium exposure. 
Genes significant in either apoptotic processes or cell proliferation were individually tested for, 
and the samples were standardized utilizing GAPDH (gene-GAPDH). Tissue for extraction was 
placed in Trizol solution and homogenized before chloroform was added. The sample underwent 
a series of purifications with buffer and isopropyl alcohol, with intermittent rounds of 
centrifugation. Purified RNA was converted to cDNA for further analysis by combining RNA 
template, Ready Script cDNA, and RNAase/DNAase free water in a 0.2 mL tube. The tube was 
centrifuged and incubated for a total of 40 minutes at increasing temperatures. Diethyl 
pyrocarbonate (180 mL) was added to the 20 µL cDNA before qPCR was run. For statistical 
analysis, the fold change was calculated using the formula 2-𝛥𝛥CT. 
Statistics and Statistical Significance 
 When interpreting results, P-values less than 0.05 were considered statistically 
significant, and p-values greater than 0.05 but less than 0.1 were considered marginally 
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significant. Marginal significance is denoted by a ▲, while statistical significance is denoted by 
a ✱. A logistic model curve fitting was used to determine the lethal dose 50 (LD50) from the 
survival rates. The statistical significance of the survival rate and visually identified qualitative 
phenotypes were grouped by treatment day and dosage and analyzed for statistical significance 
using the Fisher’s exact test. Two-sample t-tests comparing the control group and treatment 
groups were performed to analyze the statistical significance of myocardium area.  
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* 
CHAPTER III 
RESULTS AND DISCUSSION 
 
 
Effect of Cd on Survival Rate and LD50 
As our preliminary study, the objective was to determine the effect of treatment time on 
survival rate and LD50. Survival rate was determined for each embryo at the time of collection 
and recorded in Table 2. Fisher's exact test showed a statistically significant decrease in survival 
rate in HH 13-16 embryos with exposure to increasing concentrations of cadmium when grouped 
together and compared to the control. Survival rate at day 2 100 µM was significantly decreased 
at 12.5%, while day 5 exposure embryos showed no significant change in survival rates. This 
decrease in survival rate in day 2 embryos suggests early exposure to cadmium increases the risk 
of embryonic death.  
Table 2. Survival rate is lower in day 2 treated embryos compared to day 5 
Treatment Treatment Time 
HH 13-16 (Day 2) HH 27-28 (Day 5) 
Saline 100% (n=14) 88.89% (n=9)  
10 μM 100% (n=10) 93.75% (n=16) 
50 μM 90.91% (n=11) 94.12% (n=17) 
100 μM 12.50% (n=8)  66.67% (n=15) 
 
The lethal dose 50 is the amount of toxin sufficient to skill 50% of the population. A 
logistic model curve was used to generate the LD50 for day 2 and day 5 embryos. The LD50 in 
HH 13-16 embryos was 69.179, and the LD50 in HH 27-28 embryos was 98.379 (Figure 3). 
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Both survival rate and LD50 decreased with early exposure to cadmium. This indicates that early 
exposure embryos are more sensitive to the effects of cadmium than later exposure embryos.   
 
Figure 3. LD50 for early exposure embryos is lower than LD50 in later exposure embryos 
 
Effect of Cd on Hyperplastic Myocardium Phenotype Expression  
Determination of ventricular hyperplasia was performed by qualitatively comparing 
treatment samples to their corresponding controls. Examples of images utilized to diagnose left 
and right ventricles are seen below in Figure 4. The saline controls at each day are indicative of 
normal ventricular development, while the CdCl2 treated embryos in Figure 4 were all 
considered to possess evidence of hyperplasia. Visual identification of the hyperplastic 
phenotype suggested an increase in frequency of hyperplastic myocardium with earlier exposure 
and greater Cd dosage. 
16 
 
Figure 4. Visualization of hyperplastic myocardium for experimental groups compared to saline 
control 
 
 
Effect of Cd on Myocardium Percentage 
 Myocardium percentages were calculated by both students individually for the left and 
right ventricles for day 2 and day 5 embryos. In day 2 (Figure 5 a-d), the experimental 
concentrations grouped together show a statistically significant increase in myocardium 
percentage for both students in the left and right ventricles. For both students, the day 2 left 
ventricle myocardium percentages showed a statistically significant increase in response to 
CdCl2 at 50 µM and 100 µM (p=0.000 [student 1], p=0.000 [student 2]). For day 2 right 
ventricle, there was a statistically significant increase at 10 µM, 50 µM, and 100 µM. At day 2, 
the right ventricle showed a greater increase in myocardium percentage from control to 
experimental groups than the left ventricle for both students. In day 5 right ventricle (Figure 5 e-
h) myocardium percentages increased for all three experimental doses of CdCl2 as well as when 
the 10 µM, 50 µM, and 100 µM were grouped together and compared to the saline control (p= 
0.078, 0.0004, 0.017, 0.002 [student 2], p=0.093, 0.001, 0.027, 0.005 [student 3]). In the left 
ventricle, myocardium % increases at 10 µM (p=0.029 [student 2], p=0.005 [student 3], but then 
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decreases at higher concentrations for both students. For day 5 left ventricle, when all 
experimental groups were compared to the control, there was only statistical significance in one 
student’s data set (p=0.012 [student 2],  p=0.174 [student 1]). The earlier exposure day 2 samples 
showed a greater increase in myocardium percentages than day 5. Additionally, the right 
ventricle is more sensitive to cadmium induced myocardium changes than the left ventricle. With 
the exception of student 1’s day 5 LV data, increased cadmium levels lead to an increase in 
myocardium % when compared to the saline control. This suggests that Cd exposure-response is 
exacerbated by increasing dosage and exposure at earlier developmental stages.  
a.                                b. 
       
c.                                  d. 
            
Figure 5 a-d. Increasing concentrations of cadmium at earlier exposure times increases overall 
myocardium percentage a. Day 2 LV myocardium % measurements by student 1 b. Day 2 LV 
myocardium % measurements by student 2 c. Day 2 RV myocardium % measurements by 
student 1 d. Day 2 RV myocardium % measurements by student 2  
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e.                                   f.  
             
g.                                   h. 
               
Figure 5 e-h. Increasing concentrations of cadmium at earlier exposure times increases overall 
myocardium percentage e. Day 5 LV myocardium % measurements by student 1 f. Day 5 LV 
myocardium % measurements by student 2 g. Day 5 RV myocardium % measurements by 
student 1 h. Day 5 RV myocardium % measurements by student 2  
 
Cd and Zn Uptake 
The objective of ICP-MS was to observe how concentrations of Cd and Zn change based 
on length of exposure to each metal. We hypothesized that increased exposure to cadmium 
would result in increased uptake of cadmium into the embryo and therefore decreased 
concentrations in the yolk. In day 2 injection of cadmium (Figure 6 a), there was a statistically 
significant increase (p=0.0109) in cadmium concentration in the yolk at 10 µM in the day 9 
embryos when compared to day 5. Day 2 zinc injection did not show any significant relationship 
between time of exposure and zinc concentrations in the yolk, though a slight decrease in zinc 
concentration in the treated groups compared to saline was present (Figure 6 b). Likewise, day 5 
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injection day 9 collection of cadmium in Figure 6 c did not show any significant uptake of Cd 
into the embryo. However, increasing concentrations of cadmium in day 5 injection day 9 
collection embryos (Figure 6 d) lead to a decreased amount of zinc in the yolk when compared to 
saline at 50 µM (p=0.013) and 100 µM (p=0.0046). There was also a significant decrease in zinc 
levels between 10 µM and 50 µM (p=0.0152) and between 10 µM and 100 µM (p=0.0056). As 
Cd concentrations increase, it appears more zinc is taken up into the embryo for use. Cadmium is 
hypothesized to share a transport pathway with zinc21 and may provide insight into cadmium’s 
mechanism of toxicity. 
    a.                                                                                    b.                                                     
             
     c.                                                                                     d.    
                            
Figure 6 a-d. Comparison of cadmium and zinc concentrations in day 5 and day 9 collection 
groups a. Day 2 injection with cadmium, collection at day 5 or day 9 b. Day 2 injection with 
zinc, collection at day 5 or day 9 c. Day 5 injection with cadmium, collection at day 9 d. Day 5 
injection with zinc, collection at day 9 
  
✱ 
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Effect of Cd on Ventricle Wall Thickness  
As a continuation of our single-blinded study, four students from the Xie lab individually 
conducted measurements on the ventricular walls of all samples using ImageScope software in a 
single-blinded manner, shown in Figure 7 a-d. 
 
Figure 7 a-d. Individual ventricle wall thickness measurements show minimal statistical 
significance due to a large intrapersonal variability. Each L1, L2, etc. represents a different 
student who performed the measurements a. Ventricle wall thickness measurements day 2 left 
ventricle b. Ventricle wall thickness measurements day 2 right ventricle c. Ventricle wall 
thickness measurements day 5 left ventricle d. Ventricle wall thickness measurements day 5 right 
ventricle 
 
This study design introduced sufficient intrapersonal variability that made it difficult to 
deduce any clear trends. Utilizing the ImageScope software, it was difficult to uphold standard 
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criteria between students. Ventricular wall thickness showed an overall increase in response to 
cadmium treatment. However, the amount of fluctuation between measurements made it difficult 
to derive any sort of conclusion from the data. A statistical analysis was performed on our data 
collected from ventricle measurements of both chicken and mice exposed to Cd. The data 
showed no significant difference in ventricular thickness between Cd-treated samples and the 
control in either animal. If this type of study were to be repeated in the future, stricter and more 
standardized protocol would have to be implemented and consistently monitored for each 
student.  
Effect of Cd on Occurrence of Heart Defects  
Our study aimed to observe the presence of four heart defects: double outlet right 
ventricle (DORV), persistent truncus arteriosus (PTA), overriding aorta (OA), and ventricular 
septal defects (VSD). Defects were observed in day 2 and day 5 injection samples that were 
collected on day 9. No OA or VSD were present in any of the hearts. A pairwise Fisher's Exact 
test was performed on the data in Table 3, and no statistical significance between cadmium 
exposure and incidence of heart defects was detected at day 2 embryos or day 5 embryos.  
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Table 3. Heart defects present in cadmium treated embryos showed no statistical significance 
based on dose or exposure period 
a. 
 
 
 
Day 2 
Treatments 
DORV PTA 
OFT defect 
(DORV or 
PTA) 
Positive 
(+) Normal 
Positive 
(+) Normal 
Positive 
(+) Normal 
Saline 1 7 0 7 1 7 
10 uM 2 8 1 8 3 8 
50 uM 2 7 1 7 3 7 
100 uM 0 1 0 1 0 1 
 
b. 
 
Day 5 
Treatments 
DORV PTA 
OFT defect 
(DORV or 
PTA) 
Positive 
(+) Normal 
Positive 
(+) Normal 
Positive 
(+) Normal 
Saline 3 5 0 5 3 7 
10 uM 3 7 1 7 4 8 
50 uM 1 5 0 5 1 7 
100 uM 1 4 0 4 1 1 
Notes. Positive indicates the presence of the heart defect, while normal indicates the lack of a 
heart defect a. Heart defects in day 2 treated embryos b. Heart defects in day 5 treated embryos 
 
Effect of Cd on Occurrence of Limb Defects 
Qualitative visualization of limbs, seen in Table 4, showed no absence of limbs 
associated with cadmium chloride treatment in the early exposure group or the later exposure 
group.  
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Table 4. Limb defect analysis on both collection groups showed no observable absence of limbs 
with Cd treatment  
a.  
 Forelimb Hind Limb 
D2 at D9 Absent Present Absent Present 
Saline 0 5 0 5 
10 uM 0 9 0 9 
50 uM 0 10 0 10 
100 uM 0 1 0 1 
 
b. 
 Forelimb Hind Limb 
D5 at D9 Absent Present Absent Present 
Saline 0 8 0 8 
10 uM 0 15 0 15 
50 uM 0 15 0 15 
100 uM 0 8 0 8 
Notes. a. Limb analysis for embryos injected at day 2 and collected at day 9 b. Limb analysis for 
embryos injected at day 5 and collected at day 9 
 
qPCR Analysis  
Genes integral to proliferation and apoptosis were identified and analyzed. HH 27-28 
ventricles from HH 13-16 CdCl2 treated samples showed a marginal downregulation in Cyclin E 
(cyc E) in the 50 μM dose (Figure 8). Cyc-e is a proliferative gene involved in regulating cyclin 
dependent kinase and other protein kinase activity. HH 27-28 ventricles from CdCl2 treated 
samples showed significant downregulation in Apo2L at and marginal downregulation of Fas at 
dose 10 μM (Figure 9). Apo2L is involved in cytokine activity metal ion binding which induces 
apoptosis and is involved in the immune response. Fas is a transmembrane signaling receptor 
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activity involved in the apoptotic process as well. Ventricles from HH 27-28 CdCl2 treated 
samples showed marginal downregulation in Casp9 and Fas at dose 50 μM (Figure 9). Casp9 
activates caspases responsible for apoptosis initiation by activating cell death proteins or 
inactivating survival proteins. Overall, the qPCR results indicate that increasing concentrations 
of cadmium are associated with an overall downregulation of apoptotic genes. 
 
Figure 8. Proliferative gene results show marginal down regulation in Cyclin E in day 5 treated 
ventricles in the 50 μM dose. 1 is considered the ‘baseline/saline’, an increase above 1: 
upregulation, a decrease below 1: downregulation 
 
 
Figure 9. Genes associated with apoptotic processes show marginal down regulation in Casp9 
and Fas at dose 50 μM at day 5 treated ventricles and a significant downregulation in Apo2L. 1 is 
considered the ‘baseline/saline’, an increase above 1: upregulation, a decrease below 1: 
downregulation  
  
* 
* 
* * 
* 
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CHAPTER IV 
CONCLUSION 
 
 
Analysis  
Overall, this experiment showed that both the LD50 and survival rate decrease with an 
earlier exposure to Cd, and an earlier/larger dose of Cd causes an increase in both myocardium 
percentage and risk of hyperplastic myocardium development.  
The effective dose 50 (ED50) for the LV of day 2 and day 5 CdCl2 exposures were 
determined to be 23.703 μM and 48.033 μM, respectively through the fitting of a logistic model 
curve. The ED50 results indicate that early embryonic development has an increased sensitivity 
to Cd exposure compared to the later stages of development. This also suggests that the RV is 
more sensitive than the LV to CdCl2 treatment in both day 2 and day 5 exposures.  
Day 2 100 μM CdCl2 treatment resulted in high incidence of embryonic death. Day 2 
treated embryos had a decreased survival rate, thus proving that an earlier exposure to Cd 
increases the risk of death. Hyperplastic myocardium phenotype visual identification showed an 
increase in myocardium in both day 2 and day 5 CdCl2 treatments but more significantly in day 2 
compared to the control. This indicates that an earlier exposure to Cd increases the likelihood of 
a hyperplastic myocardium phenotype. Both the LV and RV in day 2 treated samples showed a 
dose dependent response regarding myocardium percentage increase. Day 5 treated Cd samples 
also showed an increase in myocardium percentage in the RV but is not indicative of a dose-
dependent response. Day 5 10 μM CdCl2 shows an increase in left ventricle myocardium %; 
however, this trend reverses for the LV because the myocardium percentage decreases as Cd 
dosage is increased to 50 μM, 100 μM, or grouped together. Day 2 samples showed a greater 
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myocardium percentage increase indicating that a greater Cd-exposure response was seen in 
these samples over day 5. Overall, this suggests that an increased Cd dosage causes a greater 
myocardium percentage increase. Our findings also suggest that early Cd exposure affects 
myocardium development in both a dose-dependent and time sensitive manner. 
Implications of Research 
Overall, our research indicates that exposure to Cd toxicity during the early stages of 
myocardium development results in: (1) a decreased survival rate, (2) increased hyperplastic 
phenotypes within the ventricle, (3) a greater percentage of myocardium tissue and (4) 
downregulation of apoptotic genes (Fas, Apo2L,casp9) in the ventricles. These results suggest 
that Cd exposure in early stages of fetal development has an effect on chicken embryo 
myocardium development. This study also indicated a relationship between zinc and cadmium 
uptake in the developing embryo. However, the origin of the Cd responses and mechanisms still 
remain unknown. 
Future Directions  
Due to the unforeseen events surrounding COVID-19 virus in spring 2020, completion of 
TUNEL staining data and H3S10 staining data were unavailable at the time of publication of this 
URS thesis. In the future, we hope to attain these results in order to form an enhanced picture of 
the effects of cadmium on the apoptotic and proliferative processes of cardiomyocytes. TUNEL 
staining aims to detect the presence of apoptotic cardiomyocytes, while H3S10 aims to identify 
cells going through active cell division. These results will provide further information regarding 
cadmium’s effect on myocardium development. Additionally, the lab will continue to refine 
protocol regarding visual analysis of hyperplastic phenotypes to ensure a more consistent result. 
This will also provide better insight into myocardium development in early exposure embryos. 
27 
Our study has developed a more comprehensive knowledge of the role of cadmium at 
early developmental stages as well as the role of cadmium on cardiomyocyte development. It has 
also provided additional analysis on the relationship between zinc and cadmium in the 
developing embryo. We anticipate future studies on this topic will further elucidate cadmium’s 
mechanisms of toxicity in order to better understand its role in embryonic development. 
Understanding cadmium’s role in embryonic development will be critical to implementing 
solutions to prevent cadmium induced toxicity and will be crucial in mitigating cadmium 
exposure in developing embryos.  
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